An unmet medical need vs. regulatory recommendations: how should we treat patients with hyperaldosteronism and advanced chronic kidney disease when surgery is not feasible?
Crossref DOI link: https://doi.org/10.1007/s00228-019-02774-2
Published Online: 2019-10-29
Published Print: 2020-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mikačić, Ivana https://orcid.org/0000-0001-8033-9482
Text and Data Mining valid from 2019-10-29
Version of Record valid from 2019-10-29
Article History
Received: 15 August 2019
Accepted: 24 September 2019
First Online: 29 October 2019
Compliance with ethical standards
:
: The author declares that she has no conflict of interest.